DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+15%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.15B
AUM Growth
+$2.15B
(-15%)
Cap. Flow
-$626M
Cap. Flow
% of AUM
-29.09%
Top 10 Holdings %
Top 10 Hldgs %
42.88%
Holding
121
New
14
Increased
12
Reduced
29
Closed
26
Top Buys
| 1 |
NVRO
NEVRO CORP.
NVRO
|
$56M |
| 2 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$44.6M |
| 3 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$25M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$24.3M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
$19.4M |
Top Sells
Sector Composition
| 1 | Healthcare | 70.12% |
| 2 | Financials | 3.34% |
| 3 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GWPH
1
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $134M | 6.23% | 1,008,475 +16,675 | +2% | +$2.21M |
|
|
PTLA
2
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $128M | 5.96% | 5,639,727 +1,966,000 | +54% | +$44.6M |
|
|
HZNP
3
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $117M | 5.43% | 6,434,439 -7,305,822 | -53% | -$132M |
|
|
NXTM
4
DELISTED
NxStage Medical Inc.
NXTM
| $102M | 4.76% | 4,099,175 -406,293 | -9% | -$10.2M |
|
|
AVXS
5
DELISTED
AveXis, Inc. Common Stock
AVXS
| $92.2M | 4.29% | 2,236,701 | – | – |
|
|
ADPT
6
DELISTED
Adeptus Health Inc.
ADPT
| $68.9M | 3.21% | 1,600,861 | – | – |
|
|
DBVT
7
DBV Technologies
DBVT
$264M
| $63.3M | 2.95% | 1,743,229 | – | – |
|
8
Vanda Pharmaceuticals
VNDA
$279M
| $57.2M | 2.66% | 3,435,576 -2,561,115 | -43% | -$42.6M |
|
|
NVRO
9
DELISTED
NEVRO CORP.
NVRO
| $56M | 2.6% | +536,355 | New | +$56M |
|
10
Viatris
VTRS
$12.3B
| $54.3M | 2.52% | 1,423,334 +84,000 | +6% | +$3.2M |
|
11
Xencor
XNCR
$580M
| $54.1M | 2.52% | 2,210,900 -719,586 | -25% | -$17.6M |
|
|
AERI
12
DELISTED
Aerie Pharmaceuticals, Inc.
AERI
| $50.5M | 2.35% | 1,338,829 -1,181,756 | -47% | -$44.6M |
|
|
AVDL
13
Avadel Pharmaceuticals
AVDL
$1.43B
| $50.5M | 2.35% | 4,072,809 | – | – |
|
|
AET
14
DELISTED
Aetna Inc
AET
| $42.3M | 1.97% | 366,000 | – | – |
|
|
AAC
15
DELISTED
AAC Holdings, Inc.
AAC
| $38.1M | 1.77% | 2,189,849 +40,147 | +2% | +$698K |
|
|
UAM
16
DELISTED
Universal American Corp
UAM
| $35.1M | 1.63% | 4,592,060 +269,060 | +6% | +$2.06M |
|
|
ALPN
17
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $30.3M | 1.41% | 3,732,412 | – | – |
|
18
eHealth
EHTH
$118M
| $29.6M | 1.38% | 2,640,609 | – | – |
|
|
WBA
19
DELISTED
Walgreens Boots Alliance
WBA
| $28.7M | 1.33% | 355,957 -255,500 | -42% | -$20.6M |
|
20
Humana
HUM
$36.5B
| $28.2M | 1.31% | 159,500 | – | – |
|
21
Galapagos
GLPG
$2.07B
| $27.4M | 1.27% | 423,112 -35,000 | -8% | -$2.26M |
|
|
SYRS
22
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $25.1M | 1.17% | 1,812,778 -282,442 | -13% | -$3.92M |
|
|
BOLD
23
DELISTED
Audentes Therapeutics, Inc
BOLD
| $25M | 1.16% | +1,403,653 | New | +$25M |
|
|
TSRO
24
DELISTED
TESARO, Inc.
TSRO
| $24.3M | 1.13% | +242,300 | New | +$24.3M |
|
25
DaVita
DVA
$9.85B
| $23.1M | 1.08% | 350,000 -175,000 | -33% | -$11.6M |
|